Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine
Reference46 articles.
1. Harold, John. “Harold on history: the evolution of transcatheter aortic valve replacement.” American College of Cardiology, 20 July 2017, www.acc.org/latest-incardiology/articles/2017/07/19/15/42/the-evolution-of-transcatheter-aortic-valve-replacement.
2. • Leon MB, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. The New England Journal of Medicine. 2016;374(17):1609–20 A very important paper (PARTNER B trial) that established that a transcutaneous approach to AVR has been shown to be an effective option as opposed to open surgical repair for patients with severe AS.
3. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. The New England Journal of Medicine. 2019;380(18):1695–705.
4. Cahill TJ, Chen M, Hayashida K, Latib A, Modine T, Piazza N, et al. Transcatheter aortic valve implantation: current status and future perspectives. European heart journal. 2018;39(28):2625–34.
5. • Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine. 2011;364(23):2187–98 This paper (PARTNER A trial) is the predecessor to the PARTNER B trial that showed that that there was no difference in mortality with TAVI versus open AVR.